Background
This report is made according to the requirements in Section 6-16a and 6-16b of the Norwegian Public Limited Liability Companies Act and IDEX Biometrics Executive Remuneration Policy. The report describes how the policy has been applied during 2025.
This report presents the number of shares, share subscription rights, the rights' exercise price and share price, adjusted to reflect the 100:1 share consolidation (reverse split) taking effect on record date July 4, 2025. The incentive subscription rights scheme has adjustment clauses to adjust the number of subscription rights and the exercise prices by the same 100:1 ratio.
Purpose
IDEX' Remuneration Policy adopted by the Annual General Meeting (AGM) on May 16, 2024, last reviewed and approved on May 21, 2025, provides the framework and guidelines for remuneration of the Board of Directors and
Executive Management in 2025. The purpose of IDEX Biometrics' executive management remuneration approach is to encourage a performance-based culture which is strong and sustainable, and which supports growth in shareholder value according to the company's strategy.
The Board did not propose any changes to the pay structure in 2025 and confirms there were no deviations from the Remuneration Policy in 2025.
Overall Company Performance
In 2025, IDEX underwent a major structural change, transforming from a component supplier to a product supplier. This led to a company emerging with a focused strategy, stronger market relevance, and a significantly lower cost base. IDEX delivered on four milestones, out of five, set for 2025. As a result of rigorous review processes and external timelines, the fifth objective was partially achieved, reaching approximately 25% of target (orders vs. normalised OPEX).
The Company reported total revenue amounting to $0.3 million for the financial year of 2025, compared to $0.8 million in 2024. Operating expenses for the full year 2025 amounted to $10.8 million compared to $22.7 million for the same period in 2024, yielding a cost reduction of 52%.
Following the restructuring, no share subscription rights have been issued to management and Chair of the Board.
Key Developments in Remuneration to the Board of Directors
Following the reduction to a compact board totalling three members, the full board has carried out the tasks of the Compensation Committee and Audit Committee with no additional fee for committee work. The total board remuneration for 2025 was TNOK 1 450, compared to TNOK 2 925 in 2024.
The Nomination Committee proposed to the AGM held in May 2025, that board remuneration remained at NOK 425 000 per member, with the Chair receiving an additional fee of NOK 175 000. No separate committee fees are proposed, as committee work is now an integral part of the work by the whole board. Board members may elect to receive all or part of their remuneration in shares in place of cash, calculated at 133% of the NOK amount based on the average closing price over the ten trading days prior to the AGM. This is, provided that the board member pays a subscription price per share equal to its par value of NOK 1 per share.
Key Developments in Remuneration to Executive Management
There were significant changes to the executive management team in 2025. Ms. Catharina Eklof served as CEO until 11 February 2025. Anders Storbråten was appointed CEO as of 11 February 2025 and subsequently assumed the CFO role from 30 June 2025. Kristian Flaten served as CFO until 30 June 2025. Didrik Martens was appointed CPO as of 11 February 2025, and Kjell-Arne Besseberg was appointed COO as of 1 April 2025
Total remuneration to executive management decreased by 27,23%, from $1 891 thousand in 2024 to 1 376 thousand in 2025. The proportion of fixed to variable remuneration was 60% to 100%. No variable incentive programme was in effect during 2025.
Feedback from Shareholders
The AGM approved the remuneration guidelines for executive management without significant input or comments. The remuneration for executive management is based on the Remuneration Policy adopted by the AGM, a policy available on the IDEX website in the Investor Relations section. The remuneration for the Board of Directors is proposed by the Nomination Committee and approved at the AGM.
Remuneration of the Board of DirectorsPolicy
The remuneration of the Board is based on a fixed fee as proposed by the Nomination Committee and approved at the AGM. There is no separate remuneration policy for the Board of Directors.
Remuneration Composition
Board remuneration consists of a fixed annual fee. As the full board carries out the work of the former Audit Committee and Compensation Committee, no separate committee fees are paid.
Fees cover the period from the 2024 AGM to the 2025 AGM. Board members do not participate in any variable pay, share incentive, pension or other benefit arrangements.
In addition, IDEX has a Board of Directors liability insurance policy with a reputable insurance company.
Table 1 - Remuneration Composition
Remuneration | Board of Directors |
Directors' fee | Yes |
Board committee fee | Yes |
Variable remuneration | - |
Pension | - |
Expenses | Yes |
Other benefits | - |
Severance pay | - |
Board remuneration paid in 2025
The fees in the table below represent fees approved at the Annual General Meeting on May 21, 2025. The board members did not receive any other fees in the capacity of board members.
Table 2 - Board and Committee Fee levels
Base board fee | Audit Committee | Compensation Committee | |
Chair | 600 | - | - |
Member | 425 | - | - |
The Company also reimburses relevant expenses the Board incur on their behalf to carry out their board duties.
While continuing with the compact board of three members including the chair, the full board has carried out the tasks of the Compensation Committee and Audit Committee, and no additional fee is rewarded for the committee work. The board remuneration amounts are fixed cash remuneration as approved by the respective AGMs.
In accordance with the authorization granted by the Annual General Meeting on 21 May 2025, Board members may elect to receive all or part of their Board remuneration in shares instead of cash. The number of shares is calculated at 133 percent of the NOK amount of the remuneration, based on the average closing price over the ten trading days prior to the AGM, provided that the Board member pays a subscription price per share equal to the nominal value of NOK 1 per share.
One Board member, Annika Olsson, elected to receive NOK 265,000 of her Board remuneration for the 2024-2025 service period in shares. As a result, 54,129 new shares were issued to her at a subscription price equal to the nominal value.
Table 3 - Shareholdings by the Board of Directors in 2025
As of December 31, 2025, the board of directors held shares in IDEX Biometrics ASA themselves or through subsidiary companies under their control. Board members do not receive share-based compensation in the effect of being a board member.
Table 3 below reflects 100:1 share consolidation for both 2024 and 2025.
Name | Position | Number of shares 31 Dec. 2024 | Number of shares 31 Dec. 2025 | Market value 31 Dec, 2025 (USD thousand) |
Morten Opstad | Chair of the Board | 24,798 | 1,576,901 | 993 |
- Warrants | 10,000 | - | - | |
Annika Olsson | Board member | 526 | 154,235 | 97 |
Adriana Saitta | Board member | - | - | - |
Total shares | 35,324 | 1,731,136 | 1,090 |
Changes in the remuneration to the board of directors
Table 4 - Remuneration of the Board of directors
2021* | Chg | 2022 | Chg | 2023 | Chg | 2024** | Chg | 2025 | |
Board of Directors Remuneration | |||||||||
Morten Opstad1 | 510 | 0% | 510 | 0% | 510 | -17% | 425 | 41% | 600 |
Annika Olsson2 | 425 | 0% | 425 | 0% | 425 | 0% | 425 | ||
Adriana Saitta3 | 475 | -11% | 425 | ||||||
Subtotal current members | 510 | 83% | 935 | 0% | 935 | 42% | 1,325 | 9% | 1,450 |
Former Board member | |||||||||
Lawrence John Ciaccia4 | 510 | 0% | 510 | 0% | 510 | 8% | 550 | ||
Deborah Davis5 | 575 | 13% | 650 | 0% | 650 | -18% | 535 | ||
Stephen A. Skaggs6 | 510 | 18% | 600 | 0% | 600 | -14% | 515 | ||
Hanne Høvding7 | 450 | 17% | 525 | 0% | 525 | ||||
Thomas M. Quindlen8 | 280 | 88% | 525 | 0% | 525 | ||||
Subtotal former members | 2,325 | 21% | 2,810 | 0% | 2,810 | -43% | 1,600 | ||
Total Board of Directors | 2,835 | 32% | 3,745 | 0% | 3,745 | -22% | 2,925 | -50% | 1,450 |
* Fees for audit committee members reflect that the committee was active from the first quarter of 2021.
** Fees for committee members reflect that the committee fees were reduced in 2024.
Mr. Opstad was chair of the board until the 2023 annual general meeting. He was again elected chair at the 2024 annual general meeting.
Ms. Olsson was elected to the board at the 2021 annual general meeting.
Ms. Saitta was elected to the board at the 2023 annual general meeting. She was member of the Audit Committee in the period that remuneration paid in 2024 related to.
Mr. Ciaccia was elected chair of the board at the 2023 Annual General meeting. Mr. Ciaccia was member of the Compensation Committee in the periods that the remuneration paid in 2024, 2023, 2022 and 2021 related to. He left the board at the 2024 annual general meeting.
Ms. Davis was chair of the Compensation Committee in the periods that the remuneration paid in 2024, 2023, 2022 and 2021 and related to. Ms. Davis was member of the Audit Committee in the period that remuneration paid in 2024, 2023, 2022 and 2021 related to. She left the board at the 2024 annual general meeting.
Mr. Skaggs was chair of the Audit Committee in the period that remuneration paid in 2023, 2022 and 2021 related to. He left the board at the 2024 annual general meeting.
Ms. Høvding left the board at the 2023 annual general meeting. She was member of the Audit Committee in the period that remuneration paid in 2023, 2022 and 2021 related to.
Mr. Quindlen left the board at the 2023 annual general meeting. He was a member of the Audit Committee in the period that remuneration paid in 2023 and 2022 related to. He was elected as a board member in May 2021. He was a board observer in the period that remuneration paid in 2021 related to.
Other Remuneration to Directors
Mr. Opstad is a partner at Ræder Bing advokatfirma AS. The law firm provided services amounting to USD 478 thousand in 2025 and USD 331 thousand in 2024, including fees for Mr. Opstad's executive functions amounting to USD 204 thousand in 2025 and USD 331 thousand in 2024 beyond board duty.
In June 2025, the Company carried out a personnel share placement in which employees, contractors and members of the Board were offered the opportunity to acquire shares at a subscription price of NOK 0.01 per share. A total of 299,381,600 shares were allocated under the program, corresponding to 2,993,816 shares after the 100:1 reverse split carried out on 4 July 2025. Two members of the Board, Ms. Annika Olsson and Mr. Morten Opstad, participated in the placement and were allocated 100,000 and 500,000 shares respectively.
In accordance with the terms of the program, the issuance of Offer Shares to Board members remains subject to subsequent approval by the General Meeting.
Share Subscription Rights:
IDEX does not grant incentive subscription rights to board members in their capacity as a board member.
Private Placements:
In 2025, Mr. Morten Opstad participated in three share placements. He was allocated 500,000 shares at NOK 0.01 in the June personnel placement, K-konsult AS subscribed to 128,156 shares at NOK 3.30 in the July private placement, and in December he subscribed to 100,000 shares personally and 83,333 shares through K-konsult AS at NOK 3.00 per share.
Remuneration of Executive Management PolicyThe remuneration of the Executive Management is based on the Remuneration Policy adopted by the AGM, made available on the IDEX website.
In 2025, the remuneration of executive management did not deviate from the Remuneration Policy.
Remuneration Composition
Remuneration for executives comprises a base salary, a variable short-term incentive, share-based long-term incentives, pension contribution, and other benefits. IDEX Biometrics provides the same remuneration components to its executive management as to its employees.
Table 6 - Remuneration Composition
Remuneration | Executive Management |
Fixed salary | Yes |
Short-term incentives | - |
Long-term share-based incentives | Yes |
Pension | Yes |
Expenses | Yes |
Other benefits | Yes |
Severance pay | - |
Fixed Salary
Fixed salary is the main element of cash remuneration. It reflects the executive's role, qualifications, and experience, and is reviewed annually against market levels for the industry, location, and general wage growth.
Short-Term Incentives
The Company's annual incentive programme uses revenue as a threshold - payouts are only triggered once a minimum revenue target is met and increase in line with revenue performance above that threshold. Additional measures such as product margin, operating expenses, product development, supply chain performance, and organisational improvement may also factor into the calculation.
At full target achievement, the payout may equal up to 100% of fixed salary. Where performance significantly exceeds targets, the payout may reach up to 200% of fixed salary.
The Board may also offer one-off incentive payments for the completion of key projects, capped at 25% of fixed salary per calendar year.
Due to the restructuring and strategic repositioning of the Company during 2025, no short-term incentive programme was in place and no one-off project-related payments were made.
Incentive pay is settled in cash at the end of the period in which it was earned and is only paid if the executive remains employed at the settlement date. Where an executive has not served the full period, payment is pro rata. The Board may decide to settle incentive pay in shares.
IDEX's employment contracts do not contain clawback provisions. In cases of misconduct, recovery of variable pay may or may not be enforceable depending on applicable legislation. No recovery of variable pay has been attempted or carried out in 2024 or 2025.
Long-Term Share-Based Incentives
Executives participate in the same share-based programme available to all employees: the subscription rights-based incentive programme (SR programme). The SR programme grants subscription rights with an exercise price equal to the 10-day average the share price. Subscription rights vest over four years, with 25% vesting on each anniversary of the vesting commencement date. Further details are available in the Company's executive remuneration policy at idexbiometrics.com.
Executives did not exercise any subscription rights in 2025.
The employee share purchase plan was suspended as of March 1 2024 and was not in effect during 2025.
In June 2025, the Company conducted a personnel share placement offering employees and contractors the opportunity to acquire shares at a subscription price of NOK 0.01 per share. Executive management participated on the same terms as other eligible employees.
Insurance, Pension, and Other Benefits
Executives are enrolled in the same insurance, pension, and benefits programmes as all other employees in the same location. Pension contributions are calculated on base pay only, unless additional contributions are legally required.
Expenses
In 2025 executive management received reimbursement for reasonable documented travel expenses which were necessary to carry out their duties as executives.
Contractual Arrangements
The employment agreements with the executives are set up in line with the employment agreements in the entity where the executive is employed, with any position-specific modifications.
Executive Duration Notice period Pension Termination terms
Anders Storbråten, CEO as of February 11, 2025 and CFO as of June 30, 20251
Individual contractor, open-ended service agreement with IDEX Biometrics ASA
3 months Not applicable 3 months fee. No
other post-employment pay or benefits.
Kjell-Arne Besseberg, COO as of April 1, 20252
Individual contractor, open-ended service agreement with IDEX Biometrics ASA
3 months Not applicable 3 months fee. No
other post-employment pay or benefits.
Didrik Martens, CPO as of February 11, 20253
Individual contractor, open-ended service agreement with IDEX Biometrics ASA
3 months Not applicable 3 months fee. No
other post-employment pay or benefits.
Catharina Eklof, CEO until February 11, 20254
Individual contractor, open-ended service agreement with IDEX Biometrics ASA
6 months Not applicable 12 months fee
unless terminated for cause. No other post-employment pay or benefits.
Kristian Flaten, CFO until June 28, 2025
Open-ended employment agreement with IDEX Biometrics ASA
4 months 5% up to 12G5 and additional 5% from
7.1G to 12G.
Non-compete clause for up to 12 months may be invoked by IDEX against paying compensation.
Anthony Eaton, CTO until January 31, 2025
Open-ended employment agreement with IDEX Biometrics UK Ltd.
3 months IDEX Biometrics UK Ltd. program: Minimum company contribution 2% and the company will match employee contribution up to 6%.
Non-compete clause for up to 6 months may be invoked by IDEX against paying compensation.
Mr. Storbråten is hired as an individual contractor. Mr. Storbråten also assumed the CFO role from 30 June 2025. No additional fee applied for CFO Services, and termination of CFO Services may be affected
separately with 30 days' notice and without additional severance.
Mr. Besseberg is hired as an individual contractor through Pinchcliffe AS owned by Mr. Storbråten.
Mr. Martens is hired as an individual contractor through Pinchcliffe AS owned by Mr. Storbråten.
Ms. Eklof is hired as an individual contractor because IDEX does not have a subsidiary in Belgium.
5G is the base amount in the Norwegian national insurance. As of May 1, 2025 it is NOK . 130,160.
Table 7 - Actual Remuneration of Executive Management
Amounts in USD thousand.
Fixed remuneration
Variable remuneration
Total remuneration
Name and position
Year
Base salary
Other1
Pension
Total Fixed Salary
% of total
Bonus2
Share-based3
Total variable
% of total
Current management
Anders Storbråten, CEO and CFO4
2025
521
-
-
521
60%
360-
-
-
40%
881
Kjell-Arne Besseberg, COO5
2025
111
-
-
111
100%
-
-
-
0%
111
Didrik Martens, CPO6
2025
105
-
-
105
100%
-
-
-
0%
105
Subtotal current management
2025
737
-
-
737
100%
-
-
-
0%
737
Former management
Catharina Eklof, CEO7
2025
101
-
-
101
100%
-
0%
101
2024
458
-
-
458
66%
109
125
234
34%
692
2023
466
-
-
466
77%
72
64
136
23%
602
2022
398
-
-
398
78%
-
114
114
22%
512
2021
259
-
-
259
58%
76
108
184
42%
443
Kristian Flaten, CFO8
2025
149
3
9
161
100%
-
-
-
0%
161
2024
30
-
-
30
100%
-
-
-
0%
30
Anthony Eaton, CTO9
2025
10
-
-
10
100%
-
-
-
0%
10
2024
234
16
-
250
64%
21
109
130
36%
380
2023
249
24
-
273
66%
82
48
130
34%
403
2022
237
14
-
251
76%
-
74
74
24%
325
2021
254
18
-
272
76%
22
60
82
24%
354
Vincent Graziani, CEO10
2025
14
-
-
14
100 %
-
-
-
-
14
2024
261
1
-
262
58%
62
128
190
42%
452
2023
360
28
-
388
68%
62
108
170
32%
558
2022
400
26
-
426
74%
-
139
139
26%
565
2021
400
25
-
425
70%
44
126
170
30%
595
John Kurtzweil, CFO11
2024
336
-
-
336
100%
-
1
1
0%
337
2023
55
-
55
98%
1
1
2%
56
Eileen Wynne, interim
CFO12
2023
141
-
141
100%
-
-
-
0%
141
2022
37
-
37
100%
-
-
-
0%
37
2021
32
-
32
100%
-
-
-
0%
32
Jamie Simms, CFO13
2022
290
21
-
311
124%
-
(56)
(56)
-24%
255
2021
211
20
-
231
54%
-
180
180
46%
411
Derek D'Antilio, CFO14
2021
100
10
-
110
76%
56
(25)
31
24%
141
Subtotal former management
2025
260
10
9
279
100%
-
-
-
0%
279
2024
1,319
17
-
1,336
70%
192
363
555
30%
1,891
2023
1,271
52
-
1,323
74%
216
221
437
26%
1,760
2022
1,362
61
-
1,423
83%
-
271
271
17%
1,694
2021
1,256
73
-
1,329
66%
198
449
647
34%
1,976
Total
2025
997
10
9
1,016
74%
360 -
-
-
26%
1,376
2024
1,319
17
-
1,336
70%
192
363
555
30%
1,891
2023
1,271
52
-
1,323
74%
216
221
437
26%
1,760
2022
1,362
61
-
1,423
83%
-
271
271
17%
1,694
2021
1,256
73
-
1,329
66%
198
449
647
34%
1,976
Benefits such as medical and life insurance.
Variable pay is reported in the year it is paid, which will be the year following the performance year, when results are known. The last year for which a variable pay was awarded, was 2022. The bonus was paid in four instalments in the third quarter 2023 to second quarter 2024.
The reported amount is the amortised cost in the year under IFRS 2 Share-based payments, In 2022 and 2021 the ESPP cost component was the nominal discount on shares acquired. Both amounts represent an upfront calculation and do not represent any gains from the plans.
Mr. Storbråten was appointed CEO as of March 11, 2025 and as a CFO as of June 30, 2025. Mr. Storbråten is an individual contractor on assignment for IDEX through Solan & Ludvig AG. Mr. Storbråten received a fee of USD 360 thousand for negotiating improved terms for the convertible loan with Heights prior to assuming the CEO position.
Mr. Besseberg was appointed COO as of April 1, 2025. Mr. Besseberg is an individual contractor on assignment for IDEX through Pinchcliffe AS.
Mr. Martens was appointed CPO as of March 11, 2025. Mr. Martens is an individual contractor on assignment for IDEX through Pinchcliffe AS.
Ms. Eklof served as CEO from as of 19 August 2024 to March 11, 2025. Ms. Eklof is an individual contractor on assignment for IDEX. Prior to becoming CEO as of 19 August 2024, she was Chief commercial officer since July 1, 2021. The salary and incentive amounts reported are the gross invoiced amounts which cover also employer's taxes and other employment benefits. The 2021 incentive was a sign-on fee. The bonus paid in 2024 was two last installments of the 2022 incentive and a signon fee for the CEO position.
Mr. Flaten served as CFO from November 2024 to June 2025.
Mr. Eaton left IDEX on January 31, 2025.
Mr. Graziani left the position of CEO as of August 19, 2024. He was appointed CEO as of March 1, 2020. He had a voluntary 20% pay reduction in the second half of 2023. Until June 30, 2025, Mr. Graziani was a contracted adviser for a fixed fee of
$3,500 per month.
Mr. Kurtzweil was an individual contractor in the CFO position September 2023-October 2024. The salary and incentive
amounts reported are the gross invoiced amounts which cover also employer's taxes and other employment benefits.
Ms. Wynne was contracted interim CFO from August 2022 to September 2023. Prior to then, she supported IDEX on a consulting basis. The salary and incentive amounts reported are the gross invoiced amounts which cover also any employer's taxes and other employment benefits.
Mr. Simms served as CFO from April 2021 to August 2022. The salary and incentive amounts reported are the gross invoiced amounts which cover also employer's taxes and other employment benefits.
Mr. D'Antilio served as CFO from July 2019 to April 2021
Share-based remuneration reflects IFRS 2 cost recognized in the period. No share-based remuneration was recognized for executive management in 2025.
Table 8 - Shareholdings by Executive Management in 2025
As of December 31, 2025, reflecting the 100:1 share consolidation.
Name | Position | Number of shares 31 Dec. 2024 | Number of shares 31 Dec. 2025 | Market value 31 Dec, 2025 (USD thousand) |
Current management | ||||
Anders Storbråten | CEO and CFO | - | 17,744,775 | 11,091 |
Kjell-Arne Besseberg | COO | - | 300,000 | 188 |
Didrik Martens | CPO | - | 250,000 | 156 |
Total | - | 18,294,775 | 11,435 | |
Former management | ||||
Catharina Eklof | Former CEO | 16,846 | - | - |
Vincent Graziani | Former CEO | 5,712 | - | - |
Kristian Flaten | Former CFO | 10,000 | 250,000 | 156 |
Anthony Eaton | Former CTO | 569 | - | - |
Total | 33,127 | - | - |
Table 9 - Incentive Share Subscription Rights Owned by Executive Management in 2025
Number of incentive subscription rights. None of the current Executive management holds subscription rights as of 31 December 2025.
Grant date | Program | Strike price (NOK) | Expiry date | Holding Jan 31, 2025 | Granted 2025 | Exercised 2025 | Terminated / Forfeited 2025 | Of which vested per Dec 31, 2025 | Holding 31 Dec, 2025 |
Former management | |||||||||
Catharina Eklof , CEO | |||||||||
2024 | 2024 SR | 145 | May 16, 2029 | 30,000 | - | - | 30,000 | - | - |
2024 | 2024 SR | 93 | May 16, 2029 | 15,000 | - | - | 15,000 | - | - |
2024 | 2024 SR | 15 | May 16, 2029 | 1,500 | - | - | 1,500 | - | - |
2023 | 2023 SR | 340 | May 23, 2028 | 1,262 | - | - | 1,262 | 315 | - |
2022 | 2022 SR | 590 | May 12, 2027 | 421 | - | - | 421 | 210 | - |
2021 | 2021 SR | 1190 | May 12, 2026 | 4,000 | - | - | 4,000 | 3,000 | - |
Total | 52,182 | - | - | 52,182 | 3,525 | - | |||
Vincent Graziani , CEO | |||||||||
2024 | 2024 SR | 145 | May 16, 2029 | 15,000 | - | - | 15,000 | - | - |
2024 | 2024 SR | 15 | May 16, 2029 | 2,500 | - | - | 2,500 | - | - |
2023 | 2023 SR | 340 | May 23, 2028 | 5,000 | - | - | 5,000 | 1250 | - |
2022 | 2022 SR | 590 | May 12, 2027 | 2,421 | - | - | 2,421 | 1,210 | - |
2021 | 2021 SR | 1200 | May 12, 2026 | 2,421 | - | - | 2,421 | 1,816 | - |
Total | 27,342 | - | - | 27,342 | 4,276 | - | |||
Kristian Flaten , CFO | |||||||||
2024 | 2024 SR | - | - | - | - | - | - | ||
Total | - | - | - | - | - | - | |||
John Kurtzweil , CFO | |||||||||
2023 | 2023 SR | 230 | May 23, 2028 | 250 | - | - | - | - | 250 |
Total | 250 | - | - | - | - | 250 | |||
Anthony Eaton , CTO | |||||||||
2024 | 2024 SR | 145 | May 16, 2029 | 30,000 | - | - | - | - | 30,000 |
2024 | 2024 SR | 15 | May 16, 2029 | 1,500 | - | - | - | - | 1,500 |
2023 | 2023 SR | 340 | May 23, 2028 | 1,262 | - | - | - | 315 | 1,262 |
2022 | 2022 SR | 590 | May 12, 2027 | 421 | - | - | - | 210 | 421 |
2021 | 2021 SR | 1040 | May 12, 2026 | 1,674 | - | - | - | 837 | 1,674 |
2021 | 2021 SR | 1200 | May 12, 2026 | 421 | - | - | - | 315 | 421 |
Total | 35,277 | - | - | - | 1,678 | 35,277 | |||
Total executive team | 115,051 | - | - | 79,524 | 8,354 | 35,527 | |||
The only vesting condition for the incentive subscription rights is continued employment or engagement as an individual contractor with IDEX. No additional performance-based or financial vesting criteria apply.
KPIs for Variable Remuneration and Goal Achievement for 2025Due to the Company's financial situation throughout 2025, there was no variable incentive programme in effect during
the year. The Board determined that the financial conditions did not support activation of the annual incentive plan.
If a variable incentive programme is in place, this section will provide an overview of a performance criteria, the relative weighing of the criteria, and how a measured performance yields a resulting remuneration.
Remuneration and Company Performance 2021 - 2025
A summary of the board and executive management remuneration for the year 2021 to 2025 and comparative information is provided in the table below.
Table 10 - Comparative Information on the Change of Remuneration and Company Performance
All amounts USD thousand. Board remuneration in NOK thousand is presented in NOK
2021 | 2022 | 2023 | 2024 | 2025 | |
Executive Management Remuneration | |||||
Anders Storbråten, CEO and CFO1 | - | - | - | - | 881 |
Kjell-Arne Besseberg, COO2 | - | - | - | - | 111 |
Didrik Martens, CPO3 | - | - | - | - | 105 |
Subtotal current management | - | - | - | - | 1 097 |
Catharina Eklof, CEO1 | 443 | 512 | 602 | 692 | 101 |
Vincent Graziani, CEO1 | 595 | 565 | 558 | 452 | 7 |
Anthony Eaton, CTO4 | 354 | 325 | 403 | 380 | 10 |
Kristian Flaten, CFO5 | - | - | - | 30 | 161 |
John Kurtzweil, CFO6 | - | - | 56 | 337 | - |
Eileen Wynne, interim CFO7 | 32 | 37 | 141 | - | - |
Jamie Simms, CFO8 | 411 | 255 | - | - | - |
Derek D'Antiliio, CFO9 | 141 | - | - | - | - |
Subtotal former management | 1,976 | 1,694 | 1,760 | 1,891 | 279 |
Total executive management | 1,976 | 1,694 | 1,760 | 1,891 | 1376 |
Company Performance | |||||
Revenue | 2,840 | 4,091 | 4,138 | 841 | 254 |
Net Loss | (32,552) | (32,662) | (26,629) | (14,449) | (10,002) |
Number of staff at year end10 | 95 | 90 | 87 | 39 | 26 |
Average remuneration of a full-time equivalent employee11 | 213 | 195 | 200 | 181 | 157 |
CEO over average staff member | 2.8 | 2.9 | 2.8 | 3.8 | 3.4 |
COO over average staff member | 2.1 | 2.6 | 3.0 | na | na |
CFO over average staff member | 1.7 | 1.7 | 0.7 | 1.9 | na |
CTO over average staff member | 1.7 | 1.7 | 2.0 | 2.1 | - |
There was a change of CEO in 2024 and again in 2025. Mr. Storbråten was appointed CEO as of February 11, 2025. Mr. Storbråten is a contractor and the reported number is the gross invoiced amount which covers also employer's taxes and benefits. Ms. Eklof was CEO from August 19, 2024 to February 11, 2025. She was formerly Chief commercial officer, and the full pay in 2024 has been included. Ms. Eklof was a contractor and the reported number is the gross invoiced amount which covers also employer's taxes and benefits. Mr. Graziani was CEO from 2021 and to August 19, 2024.
There was a change of C0O in 2021 and again in 2025. Mr. Besseberg was appointed COO April 1, 2025. Mr. is a contractor and
the reported number is the gross invoiced amount which covers also employer's taxes and benefits. Ms. Eklof was COO until August 19, 2024.
Mr. Martens was appointed CPO February 11, 2025. He is a contractor and the reported number is the gross invoiced amount
which covers also employer's taxes and benefits.
Mr. Eaton left his position as CTO January 31, 2025.
There was a change of CFO in 2021, 2022, 2023, 2024 and 2025. Mr. Storbråten was appointed as CFO June 30, 2025. Mr.
Flaten was CFO from November 1, 2024 to June 28, 2025.
Mr. Kurtzweil was CFO from September 2023 to October 31, 2024. Ms. Kurtzweil was a contractor and the reported number is
the gross invoiced amount which covers also employer's taxes and benefits.
Ms. Wynne was interim CFO from August 2022 to September 2023. Ms. Wynne was a contractor and the reported number is
the gross invoiced amount which covers also employer's taxes and benefits.
Mr. Simms was CFO from April 2021 to August 2022. Mr. Simms was a contractor and the reported number is the gross
invoiced amount which covers also employer's taxes and benefits.
Mr. D'Antilio was CFO from July 2019 to April 2021.
Staff includes both employees and individual contractors engaged by IDEX.
Salary for employees and full fee for individual contractors.
As per the date of this document, the Board of Directors has considered and approved the Remuneration Report of IDEX Biometrics ASA for the financial year of 2025.
The Board of Directors confirms that this remuneration report has been prepared in accordance with Section 6-16b of the Norwegian Public Limited Liability Companies Act and supplementing regulations. The remuneration report will be presented to the Annual General Meeting in May 2026 for an advisory vote. The remuneration report is signed electronically.
April 30, 2026
The Board of Directors of IDEX Biometrics ASA
/s/ Morten Opstad Morten Opstad Chair
/s/ Annika Olsson Annika Olsson Board member
/s/ Adriana Saitta Adriana Saitta Board member
/s/ Anders Storbråten Anders Storbråten CEO
